CGP 36742

CAT:
804-HY-121599-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
CGP 36742 - image 1

CGP 36742

  • Description :

    CGP 36742 (SGS-742) is an orally active and selective antagonist of GABAB receptor (IC50 = 36 µM) . CGP 36742 is a blood-brain barrier (BBB) penetrant compound and improves cognitive performances. CGP 36742 can be used for depression study[1][2][3][4].
  • Product Name Alternative :

    SGS-742
  • UNSPSC :

    12352211
  • Hazard Statement :

    H302, H319
  • Target :

    GABA Receptor
  • Type :

    Reference compound
  • Related Pathways :

    Membrane Transporter/Ion Channel; Neuronal Signaling
  • Applications :

    Neuroscience-Neuromodulation
  • Field of Research :

    Neurological Disease
  • Assay Protocol :

    https://www.medchemexpress.com/cgp-36742.html
  • Purity :

    98.0
  • Solubility :

    H2O : 125 mg/mL (ultrasonic)
  • Smiles :

    O=P(CCCN)(O)CCCC
  • Molecular Formula :

    C7H18NO2P
  • Molecular Weight :

    179.20
  • Precautions :

    H302, H319
  • References & Citations :

    [1]Nowak G, et al. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. Br J Pharmacol. 2006 Nov;149 (5) :581-90.|[2]Olpe HR, et al. The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. Eur J Pharmacol. 1993 Mar 23;233 (2-3) :179-86.|[3]Andrén PE, et al. Blood-brain barrier penetration of 3-aminopropyl-n-butylphosphinic acid (CGP 36742) in rat brain by microdialysis/mass spectrometry. J Mass Spectrom. 1998 Mar;33 (3) :281-7. |[4]Pittaluga A, et al. Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA (B) receptor antagonists. Neuropharmacology. 2001 Sep;41 (3) :301-10.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    Phase 2
  • CAS Number :

    [123690-78-8]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide